Lundbeck in Talks With Possible Alzheimer’s Drug Partners

H. Lundbeck A/S, the Nordic region’s second-largest drugmaker, is in talks with several potential partners to help develop a treatment for Alzheimer’s disease, Chief Executive Officer Ulf Wiinberg said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.